Vimarsana
Biggest News Aggregation in the World

Page 9 - Veeva Development Cloud News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Veeva Development Cloud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Veeva Development Cloud Today - Breaking & Trending Today

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments - Vimarsana News

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments

PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...

Veeva : Bristol Myers Squibb Discusses the Value of a Platform Services Approach - Vimarsana News

Veeva : Bristol Myers Squibb Discusses the Value of a Platform Services Approach

This year we were fortunate to have 4,000+ participants for the Veeva R&D and Quality Summit Connect, including 400+ pharma professionals in the Veeva Development Cloud and Vault Platform... | December 15, 2021

Veeva Systems (VEEV) Q3 2022 Earnings Call Transcript - Vimarsana News

Veeva Systems (VEEV) Q3 2022 Earnings Call Transcript

VEEV earnings call for the period ending September 30, 2021.

Source: fool.com
Veeva Announces Fiscal 2022 First Quarter Results - Vimarsana News

Veeva Announces Fiscal 2022 First Quarter Results

Veeva Announces Fiscal 2022 First Quarter Results Total Revenues of $433.6M, up 29% Year Over Year; Subscription Services Revenues of $341.1M, up 26% Year Over Year News provided by Share this article Share this article PLEASANTON, Calif., May 27, 2021 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2021. "The team's focus on customer success and product excellence continues to drive Veeva's outstanding results," said CEO Peter Gassner. "Our i...

Veeva Development Cloud Streamlining Drug Development Industrywide - Vimarsana News

Veeva Development Cloud Streamlining Drug Development Industrywide

Veeva Development Cloud Streamlining Drug Development Industrywide Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance News provided by Share this article Share this article PLEASANTON, Calif., May 19, 2021 /PRNewswire/ -- A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than 650 companies use Veeva Development Cloud applications today, and more than 250 are leveraging mult...